Previous Article | Next Article 
Journal of Virology, January 2001, p. 979-987, Vol. 75, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.979-987.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Strict Control of Human Immunodeficiency Virus Type
1 Replication by a Genetic Switch: Tet for Tat
Koen
Verhoef,1,
Giuseppe
Marzio,1
Wolfgang
Hillen,2
Hermann
Bujard,3 and
Ben
Berkhout1,*
Department of Human Retrovirology, Academic
Medical Center, University of Amsterdam, Amsterdam, The
Netherlands,1 and Friedrich-Alexander
University, Erlangen,2 and Zentrum
für Molekulare Biologie, University of Heidelberg,
Heidelberg,3 Germany
Received 25 July 2000/Accepted 11 October 2000
Live-attenuated human immunodeficiency virus type 1 (HIV-1)
variants have shown great promise as AIDS vaccines, but continued replication can lead to the selection of faster-replicating variants that are pathogenic. We therefore designed HIV-1 genomes that replicate
exclusively upon addition of the nontoxic effector doxycycline (dox).
This was achieved by replacement of the viral TAR-Tat system for
transcriptional activation by the Escherichia coli-derived Tet system for inducible gene expression. These designer "HIV-rtTA" viruses replicate in a strictly dox-dependent manner both in a T-cell
line and in primary blood cells, and the rate of replication can be
fine-tuned by simple variation of the dox concentration. These HIV-rtTA
viruses provide a tool to perform genetics, e.g., selection and
optimization experiments, with the E. coli-derived Tet
reagents in a eukaryotic background. Furthermore, such viruses may
represent improved vaccine candidates because their replication can be
turned on and off at will.
*
Corresponding author. Mailing address: Department of
Human Retrovirology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. Phone: (31-20) 566-5822. Fax: (31-20) 566-9064. E-mail:
b.berkhout{at}amc.uva.nl.

Present address: Department of Biochemistry, University of Oxford,
Oxford,
England.
Journal of Virology, January 2001, p. 979-987, Vol. 75, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.979-987.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vrolijk, M. M., Ooms, M., Harwig, A., Das, A. T., Berkhout, B.
(2008). Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA. Nucleic Acids Res
36: 4352-4363
[Abstract]
[Full Text]
-
Das, A. T., Klaver, B., Harwig, A., Vink, M., Ooms, M., Centlivre, M., Berkhout, B.
(2007). Construction of a Doxycycline-Dependent Simian Immunodeficiency Virus Reveals a Nontranscriptional Function of Tat in Viral Replication. J. Virol.
81: 11159-11169
[Abstract]
[Full Text]
-
Das, A. T., Harwig, A., Vrolijk, M. M., Berkhout, B.
(2007). The TAR Hairpin of Human Immunodeficiency Virus Type 1 Can Be Deleted When Not Required for Tat-Mediated Activation of Transcription. J. Virol.
81: 7742-7748
[Abstract]
[Full Text]
-
Brandt, S., Grunwald, T., Lucke, S., Stang, A., Uberla, K.
(2006). Functional replacement of the R region of simian immunodeficiency virus-based vectors by heterologous elements.. J. Gen. Virol.
87: 2297-2307
[Abstract]
[Full Text]
-
Zhou, X., Vink, M., Klaver, B., Verhoef, K., Marzio, G., Das, A. T., Berkhout, B.
(2006). The Genetic Stability of a Conditional Live HIV-1 Variant Can Be Improved by Mutations in the Tet-On Regulatory System That Restrain Evolution. J. Biol. Chem.
281: 17084-17091
[Abstract]
[Full Text]
-
Markusic, D., Oude-Elferink, R., Das, A. T., Berkhout, B., Seppen, J.
(2005). Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res
33: e63-e63
[Abstract]
[Full Text]
-
Das, A. T., Baldwin, C. E., Vink, M., Berkhout, B.
(2005). Improving the Safety of a Conditional-Live Human Immunodeficiency Virus Type 1 Vaccine by Controlling both Gene Expression and Cell Entry. J. Virol.
79: 3855-3858
[Abstract]
[Full Text]
-
Baldwin, C. E., Sanders, R. W., Deng, Y., Jurriaans, S., Lange, J. M., Lu, M., Berkhout, B.
(2004). Emergence of a Drug-Dependent Human Immunodeficiency Virus Type 1 Variant during Therapy with the T20 Fusion Inhibitor. J. Virol.
78: 12428-12437
[Abstract]
[Full Text]
-
Das, A. T., Zhou, X., Vink, M., Klaver, B., Verhoef, K., Marzio, G., Berkhout, B.
(2004). Viral Evolution as a Tool to Improve the Tetracycline-regulated Gene Expression System. J. Biol. Chem.
279: 18776-18782
[Abstract]
[Full Text]
-
Das, A. T., Brummelkamp, T. R., Westerhout, E. M., Vink, M., Madiredjo, M., Bernards, R., Berkhout, B.
(2004). Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition. J. Virol.
78: 2601-2605
[Abstract]
[Full Text]
-
Apolloni, A., Hooker, C. W., Mak, J., Harrich, D.
(2003). Human Immunodeficiency Virus Type 1 Protease Regulation of Tat Activity Is Essential for Efficient Reverse Transcription and Replication. J. Virol.
77: 9912-9921
[Abstract]
[Full Text]
-
Ciftcioglu, N., Miller-Hjelle, M. A., Hjelle, J. T., Kajander, E. O.
(2002). Inhibition of Nanobacteria by Antimicrobial Drugs as Measured by a Modified Microdilution Method. Antimicrob. Agents Chemother.
46: 2077-2086
[Abstract]
[Full Text]
-
Marzio, G., Vink, M., Verhoef, K., de Ronde, A., Berkhout, B.
(2002). Efficient Human Immunodeficiency Virus Replication Requires a Fine-Tuned Level of Transcription. J. Virol.
76: 3084-3088
[Abstract]
[Full Text]
-
Smith, S. M., Khoroshev, M., Marx, P. A., Orenstein, J., Jeang, K.-T.
(2001). Constitutively Dead, Conditionally Live HIV-1 Genomes. EX VIVO IMPLICATIONS FOR A LIVE VIRUS VACCINE. J. Biol. Chem.
276: 32184-32190
[Abstract]
[Full Text]
-
Marzio, G., Verhoef, K., Vink, M., Berkhout, B.
(2001). In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc. Natl. Acad. Sci. USA
98: 6342-6347
[Abstract]
[Full Text]